Zdrowie i gospodarka · 30/06/2022
FDA Clears MICRONOR for Approval of Norethindrone Tablets
The FDA has determined that MICRONOR (norethindrone tablets, 0.35 mg) was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of norethindrone tablets, 0.35 mg, through abbreviated new drug applications.